Lapatinib Intermediate CAS 231278-84-5 Ịdị ọcha>98.0% (HPLC)

Nkọwa dị mkpirikpi:

5-[4-[3-Chloro-4- (3-Fluorobenzyloxy) anilino]-6-Quinazolinyl]furan-2-Carboxaldehyde

Nọmba: 231278-84-5

Dị ọcha:> 98.0% (HPLC)

Ọdịdị: Acha odo odo ruo odo odo siri ike ntụ ntụ

Ọkara nke API (CAS 388082-77-7)

Kpọtụrụ: Dr. Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Lapatinib Intermediates:

Njirimara kemịkalụ:

Aha Chemical 5-[4-[3-Chloro-4- (3-Fluorobenzyloxy) anilino]-6-Quinazolinyl]furan-2-Carboxaldehyde
Ụdị okwu Lapatinib Intermediate 3;5-[4-[3-Chloro-4-[(3-Fluorophenyl) methoxy] phenyl] amino]-6-Quinazolinyl]-2-Furancarboxaldehyde;5-[4- ((3-Chloro-4- ((3-Fluorobenzyl) oxy) phenyl) amino) quinazolin-6-yl] -2-Furaldehyde
Nọmba CAS 231278-84-5
Ọnọdụ Ahịa N'ọkwa, Mpụta Ihe ruru Tọn
Usoro ihe omimi C26H17ClFN3O3
Ibu molekụla 473.90
Ebe Na-agbaze 225.0 ruo 235.0 ℃
Njupụta 1.407±0.06 g/cm3
Ntụgharị uche 1.694
COA & MSDS Dị
Mmalite Shanghai, China
Ụdị Ruifu Chemical

Nkọwapụta:

Ihe Nkọwapụta
Ọdịdị Icha mmirimmiri ruo ntụ ntụ siri ike na-acha odo odo
Ụzọ ịdị ọcha / nyocha > 98.0% (HPLC)
Ebe Na-agbaze 225.0 ~ 235.0 ℃
Ọnwụ na ihicha <1.00%
Ihe fọdụrụ na mgbanye <0.50%
Mgbakọta adịghị ọcha <2.00%
Ọla dị arọ (dị ka Pb) <20ppm
Nlele ọkọlọtọ Standardkpụrụ ụlọ ọrụ
Ojiji Ọkara nke API (CAS 388082-77-7)

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri

Uru:

1

Ajụjụ:

www.ruifuchem.com

231278-84-5 - Ngwa:

5-[4-[3-Chloro-4- (3-Fluorobenzyloxy) anilino]-6-Quinazolinyl]furan-2-Carboxaldehyde (CAS: 231278-84-5) bụ etiti API (CAS 388082-77-7) ).(CAS 388082-77-7) bụ ọgwụ ezubere iche maka ọrịa ara ara nke British GlaxoSmithKline Co. Ọ bụ tyrosine kinase inhibitor nke nwere ike igbochi ọrụ tyrosine kinase nke ọma nke ndị na-anabata ihe na-eto eto epidermal mmadụ 1 na 2 (ErbB1, ErbB2).Ọ nwere ike ime ihe n'ụzọ dị iche iche, na-ahụ na mkpụrụ ndụ kansa ara enweghị ike ịnata akara uto.Ọ na-egbochi intracellular EGFR (ErbB-1) na HER2 (ErbB-2) saịtị ATP, na-egbochi tumor cell phosphorylation na activation, igbochi ala-usoro akara ngosi site homogeneity na heterogeneity nke EGFR (ErbB-1) na HER2 (ErbB-1) dimerization.

Dee ozi gị ebe a ziga anyị ya